- Home
- SNTI vs AUST Comparison
SNTI vs AUST Comparison
Compare SNTI & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- AUST
- Stock Information
- Founded
- SNTI 2016
- AUST 2020
- Country
- SNTI United States
- AUST Canada
- Employees
- SNTI N/A
- AUST N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- AUST
- Sector
- SNTI Health Care
- AUST
- Exchange
- SNTI Nasdaq
- AUST Nasdaq
- Market Cap
- SNTI 19.1M
- AUST 15.5M
- IPO Year
- SNTI N/A
- AUST 2022
- Fundamental
- Price
- SNTI $4.67
- AUST $1.17
- Analyst Decision
- SNTI Strong Buy
- AUST
- Analyst Count
- SNTI 1
- AUST 0
- Target Price
- SNTI $12.00
- AUST N/A
- AVG Volume (30 Days)
- SNTI 115.8K
- AUST 90.4K
- Earning Date
- SNTI 11-14-2024
- AUST 03-03-2025
- Dividend Yield
- SNTI N/A
- AUST N/A
- EPS Growth
- SNTI N/A
- AUST N/A
- EPS
- SNTI N/A
- AUST N/A
- Revenue
- SNTI N/A
- AUST N/A
- Revenue This Year
- SNTI $11.52
- AUST N/A
- Revenue Next Year
- SNTI $78.57
- AUST N/A
- P/E Ratio
- SNTI N/A
- AUST N/A
- Revenue Growth
- SNTI N/A
- AUST N/A
- 52 Week Low
- SNTI $1.52
- AUST $0.62
- 52 Week High
- SNTI $16.94
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- SNTI 56.65
- AUST 40.52
- Support Level
- SNTI $3.72
- AUST $1.05
- Resistance Level
- SNTI $4.93
- AUST $1.27
- Average True Range (ATR)
- SNTI 0.46
- AUST 0.10
- MACD
- SNTI 0.01
- AUST 0.02
- Stochastic Oscillator
- SNTI 81.82
- AUST 42.86
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About AUST Austin Gold Corp.
Austin Gold Corp is a gold exploration and development company focused on gold targets and making district-scale gold discoveries in Nevada. Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Fourmile Basin in Nye County.